Results
|
1.
|
|
|
2.
|
|
|
3.
|
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials. MedStar authors:
Year: 2019
Citation: - Clinical Infectious Diseases. 69(11):1912-1918, 2019 11 13.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
All authors: - Alder J, Asehnoune K, Bassetti M, Bonten MJM, Chastre J, De Waele J, Dimopoulos G, Eggimann P, Engelhardt M, Ewig S, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer LB, Papazian L, Poulakou G, Prokocimer P, Rello J, Rex JH, Shorr AF, Talbot GH, Thamlikitkul V, Timsit JF, Torres A, Weiss E, Wunderink RG, Zahar JR
|
|
4.
|
|
|
5.
|
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. MedStar authors:
Year: 2021
Citation: - The Lancet Infectious Diseases. 21(2):213-225, 2021 02.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
All authors: - Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Matsunaga Y, Menon A, Nagata TD, Pogue JM, Shorr AF, Timsit JF, Wunderink RG, Zeitlinger M
|
|
6.
|
|
|
7.
|
|